Increased tricuspid regurgitant jet velocity by doppler echocardiography in adult survivors of childhood cancer: A report from the st jude lifetime cohort study

Journal of Clinical Oncology

Volumn 31, Issue 6, 2013, Pages 774-781

  Armstrong, Gregory T ^a   Joshi, Vijaya M ^b   Zhu, Liang ^a   Srivastava, Deokumar ^a   Zhang, Nan ^a   Ness, Kirsten K ^a   Stokes, Dennis C ^b   Krasin, Matthew T ^a   Fowler, James A ^b   Robison, Leslie L ^a   Hudson, Melissa M ^a   Green, Daniel M ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AORTA VALVE REGURGITATION; ARTICLE; BODY MASS; CANCER DIAGNOSIS; CHILD; CHILDHOOD CANCER; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; EXERCISE; FEMALE; FLOW RATE; HEART FUNCTION; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIMARY TUMOR; PRIORITY JOURNAL; SCHOOL CHILD; SURVIVOR; TRICUSPID REGURGITANT JET VELOCITY; TRICUSPID VALVE REGURGITATION; WALKING;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY, DOPPLER; EXERCISE; FEMALE; HEART FUNCTION TESTS; HUMANS; HYPERTENSION, PULMONARY; INFANT; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; RESPIRATORY FUNCTION TESTS; RISK FACTORS; SURVIVORS; TRICUSPID VALVE INSUFFICIENCY; WALKING; YOUNG ADULT;

EID: 84875735852     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.43.0702     Document Type: Article

References (46)

1. Howlader N, Noone AM, Krapcho M, et al (eds): SEER Cancer Statistics Review, 1975-2008. Bethesda, MD, National Cancer Institute, based on November 2010 SEER data submission, posted to the SEER web site, 2011. http://seer.cancer.gov/csr/1975-2008/
2. Mertens AC, Liu Q, Neglia JP, et al: Causespecific late mortality among 5-year survivors of childhood cancer: The Childhood Cancer Survivor Study. J Natl Cancer Inst 100:1368-1379, 2008
3. Heidenreich PA, Hancock SL, Vagelos RH, et al: Diastolic dysfunction after mediastinal irradiation. Am Heart J 150:977-982, 2005 (Pubitemid 41607777)
4. Hudson MM, Rai SN, Nunez C, et al: Noninvasive evaluation of late anthracycline cardiac toxicity in childhood cancer survivors. J Clin Oncol 25: 3635-3643, 2007 (Pubitemid 47372601)
5. Lipshultz SE, Lipsitz SR, Sallan SE, et al: Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia. J Clin Oncol 23:2629-2636, 2005 (Pubitemid 46179451)
6. Adams MJ, Lipsitz SR, Colan SD, et al: Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy. J Clin Oncol 22:3139-3148, 2004 (Pubitemid 41103728)
7. Weiner DJ, Maity A, Carlson CA, et al: Pulmonary function abnormalities in children treated with whole lung irradiation. Pediatr Blood Cancer 46:222- 227, 2006 (Pubitemid 43076073)
8. O'Driscoll BR, Hasleton PS, Taylor PM, et al: Active lung fibrosis up to 17 years after chemotherapy with carmustine (BCNU) in childhood. N Engl J Med 323:378-382, 1990 (Pubitemid 20243904)
9. Mann JR, Pearson D, Barrett A, et al: Results of the United Kingdom Children's Cancer Study Group's malignant germ cell tumor studies. Cancer 63:1657-1667, 1989 (Pubitemid 19110599)
10. Marina NM, Greenwald CA, Fairclough DL, et al: Serial pulmonary function studies in children treated for newly diagnosed Hodgkin's disease with mantle radiotherapy plus cycles of cyclophosphamide, vincristine, and procarbazine alternating with cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine. Cancer 75:1706-1711, 1995
11. Seguchi M, Hirabayashi N, Fujii Y, et al: Pulmonary hypertension associated with pulmonary occlusive vasculopathy after allogeneic bone marrow transplantation. Transplantation 69:177- 179, 2000 (Pubitemid 30062627)
12. Limsuwan A, Pakakasama S, Rochanawutanon M, et al: Pulmonary arterial hypertension after childhood cancer therapy and bone marrow transplantation. Cardiology 105:188-194, 2006
13. Morales IJ, Anderson PM, Tazelaar HD, et al: Pulmonary cytolytic thrombi: Unusual complication of hematopoietic stem cell transplantation. J Pediatr Hematol Oncol 25:89-92, 2003 (Pubitemid 36070973)
14. Qasim W, Gerritsen B, Veys P: Anticardiolipin antibodies and thromboembolism after BMT. Bone Marrow Transplant 21:845-847, 1998 (Pubitemid 28190634)
15. Bentur L, Cullinane C, Wilson P, et al: Fatal pulmonary arterial occlusive vascular disease following chemotherapy in a 9-month-old infant. Hum Pathol 22:1295-1298, 1991
16. Shankar S, Choi JK, Dermody TS, et al: Pulmonary hypertension complicating bone marrow transplantation for idiopathic myelofibrosis. J Pediatr Hematol Oncol 26:393-397, 2004 (Pubitemid 38747733)
17. Vaksmann G, Nelken B, Deshildre A, et al: Pulmonary arterial occlusive disease following chemotherapy and bone marrow transplantation for leukaemia. Eur J Pediatr 161:247-249, 2002 (Pubitemid 34492682)
18. Chin KM, Rubin LJ: Pulmonary arterial hypertension. J Am Coll Cardiol 51:1527-1538, 2008 (Pubitemid 351508372)
19. McLaughlin V, Humbert M, Coghlan G, et al: Pulmonary arterial hypertension: The most devastating vascular complication of systemic sclerosis. Rheumatology (Oxford) 48:iii25-iii31, 2009
20. McGoon M, Gutterman D, Steen V, et al: Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 126:14S-34S, 2004 (Pubitemid 38932340)
21. Gladwin MT, Sachdev V, Jison ML, et al: Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med 350:886-895, 2004 (Pubitemid 38252536)
22. Morris CR, Kim HY, Trachtenberg F, et al: Risk factors and mortality associated with an elevated tricuspid regurgitant jet velocity measured by Doppler-echocardiography in thalassemia: A Thalassemia Clinical Research Network report. Blood 118: 3794-3802, 2011
23. Hudson MM, Ness KK, Nolan VG, et al: Prospective medical assessment of adults surviving childhood cancer: Study design, cohort characteristics, and feasibility of the St Jude Lifetime Cohort Study. Pediatr Blood Cancer 56:825-836, 2011
24. Landier W, Bhatia S, Eshelman DA, et al: Development of risk-based guidelines for pediatric cancer survivors: The Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline. J Clin Oncol 22:4979- 4990, 2004 (Pubitemid 46638624)
25. Lang RM, Bierig M, Devereux RB, et al: Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440-1463, 2005 (Pubitemid 41821197)
26. Nagueh SF, Appleton CP, Gillebert TC, et al: Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 22:107-133, 2009
27. Badesch DB, Champion HC, Sanchez MA, et al: Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 54:S55-S66, 2009
28. Zoghbi WA, Enriquez-Sarano M, Foster E, et al: Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 16:777-802, 2003 (Pubitemid 37391035)
29. Pellegrino R, Viegi G, Brusasco V, et al: Interpretative strategies for lung function tests. Eur Respir J 26:948-968, 2005 (Pubitemid 41632054)
30. Hankinson JL, Odencrantz JR, Fedan KB: Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 159:179-187, 1999 (Pubitemid 29036522)
31. Morris AH, Kanner RE, Crapo RO, et al: Clinical Pulmonary Function Testing: A Manual of Uniform Laboratory Procedures (ed 2). Salt Lake City, UT, Intermountain Thoracic Society, 1984
32. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories: ATS statement: Guidelines for the six-minute walk test. Am J Respir Crit Care Med 166:111-117, 2002
33. Rostagno C, Olivo G, Comeglio M, et al: Prognostic value of 6-minute walk corridor test in patients with mild to moderate heart failure: Comparison with other methods of functional evaluation. Eur J Heart Fail 5:247-252, 2003 (Pubitemid 37011852)
34. Heidenreich PA, Hancock SL, Lee BK, et al: Asymptomatic cardiac disease following mediastinal irradiation. J Am Coll Cardiol 42:743-749, 2003 (Pubitemid 37000197)
35. Hancock SL, Donaldson SS, Hoppe RT: Cardiac disease following treatment of Hodgkin's disease in children and adolescents. J Clin Oncol 11:1208-1215, 1993 (Pubitemid 23199121)
36. Galié N, Torbicki A, Barst R, et al: Guidelines on diagnosis and treatment of pulmonary arterial hypertension: The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J 25:2243-2278, 2004
37. Gladwin MT, Vichinsky E: Pulmonary complications of sickle cell disease. N Engl J Med 359: 2254-2265, 2008
38. Fisher MR, Forfia PR, Chamera E, et al: Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am J Respir Crit Care Med 179:615-621, 2009
39. Janda S, Shahidi N, Gin K, et al: Diagnostic accuracy of echocardiography for pulmonary hypertension: A systematic review and meta-analysis. Heart 97:612-622, 2011
40. Rich JD, Shah SJ, Swamy RS, et al: Inaccuracy of Doppler echocardiographic estimates of pulmonary artery pressures in patients with pulmonary hypertension: Implications for clinical practice. Chest 139:988-993, 2011
41. Lipshultz SE, Vlach SA, Lipsitz SR, et al: Cardiac changes associated with growth hormone therapy among children treated with anthracyclines. Pediatrics 115:1613-1622, 2005 (Pubitemid 43843171)
42. Berry JD, Dyer A, Cai X, et al: Lifetime risks of cardiovascular disease. N Engl J Med 366:321-329, 2012
43. Huang TT, Hudson MM, Stokes DC, et al: Pulmonary outcomes in survivors of childhood cancer: A systematic review. Chest 140:881-901, 2011
44. McQuillan BM, Picard MH, Leavitt M, et al: Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects. Circulation 104:2797-2802, 2001 (Pubitemid 33126653)
45. Oeffinger KC, Mertens AC, Sklar CA, et al: Obesity in adult survivors of childhood acute lymphoblastic leukemia: A report from the Childhood Cancer Survivor Study. J Clin Oncol 21:1359-1365, 2003 (Pubitemid 46606416)
46. Pellikka PA, Nagueh SF, Elhendy AA, et al: American Society of Echocardiography recommendations for performance, interpretation, and application of stress echocardiography. J Am Soc Echocardiogr 20:1021-1041, 2007 (Pubitemid 47321932)